Literature DB >> 10584688

Painful cervical dystonia: clinical features and response to treatment with botulinum toxin.

D Tarsy1, E R First.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10584688     DOI： 10.1002/1531-8257(199911)14:6<1043::aid-mds1026>3.0.co;2-3

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  10 in total

Review 1.  [Use of botulinum toxin the the treatment of muscle pain].

Authors:  R Benecke; D Dressler; E Kunesch; T Probst
Journal:  Schmerz       Date:  2003-12       Impact factor: 1.107

2.  Botulinum toxin B in the sensory afferent: transmitter release, spinal activation, and pain behavior.

Authors:  Marc J Marino; Tetsuji Terashima; Joanne J Steinauer; Kelly A Eddinger; Tony L Yaksh; Qinghao Xu
Journal:  Pain       Date:  2013-12-11       Impact factor: 6.961

3.  Nociceptive pathway function is normal in cervical dystonia: a study using laser-evoked potentials.

Authors:  Michele Tinazzi; Massimiliano Valeriani; Giovanna Squintani; Federica Corrà; Serena Recchia; Giovanni Defazio; Alfredo Berardelli
Journal:  J Neurol       Date:  2012-02-18       Impact factor: 4.849

Review 4.  [Botulinum toxin A in orthopedic pain therapy].

Authors:  R Placzek; M Söhling; M Gessler; J Jerosch
Journal:  Schmerz       Date:  2004-12       Impact factor: 1.107

Review 5.  Drug Insight: biological effects of botulinum toxin A in the lower urinary tract.

Authors:  Michael B Chancellor; Clare J Fowler; Apostolos Apostolidis; William C de Groat; Christopher P Smith; George T Somogyi; K Roger Aoki
Journal:  Nat Clin Pract Urol       Date:  2008-05-06

Review 6.  Management of cervical dystonia with botulinum neurotoxins and EMG/ultrasound guidance.

Authors:  Anna Castagna; Alberto Albanese
Journal:  Neurol Clin Pract       Date:  2019-02

Review 7.  Botulinum neurotoxin for pain management: insights from animal models.

Authors:  Flaminia Pavone; Siro Luvisetto
Journal:  Toxins (Basel)       Date:  2010-12-21       Impact factor: 4.546

8.  Exploring factors related to physical activity in cervical dystonia.

Authors:  Lena Zetterberg; Charlotte Urell; Elisabeth Anens
Journal:  BMC Neurol       Date:  2015-12-01       Impact factor: 2.474

Review 9.  The Expanding Therapeutic Utility of Botulinum Neurotoxins.

Authors:  Elena Fonfria; Jacquie Maignel; Stephane Lezmi; Vincent Martin; Andrew Splevins; Saif Shubber; Mikhail Kalinichev; Keith Foster; Philippe Picaut; Johannes Krupp
Journal:  Toxins (Basel)       Date:  2018-05-18       Impact factor: 4.546

Review 10.  Botulinum Toxin Type a as a Therapeutic Agent against Headache and Related Disorders.

Authors:  Siro Luvisetto; Parisa Gazerani; Carlo Cianchetti; Flaminia Pavone
Journal:  Toxins (Basel)       Date:  2015-09-23       Impact factor: 4.546
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.